Castle Biosciences
CSTL
CSTL
146 hedge funds and large institutions have $491M invested in Castle Biosciences in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 72 increasing their positions, 29 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
31% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 36
50% less capital invested
Capital invested by funds: $988M → $491M (-$498M)
Holders
146
Holding in Top 10
3
Calls
$645K
Puts
–
Top Buyers
| 1 | +$13.8M | |
| 2 | +$9.74M | |
| 3 | +$9.59M | |
| 4 |
RI
RTW Investments
New York
|
+$9.16M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$7.32M |
Top Sellers
| 1 | -$52.5M | |
| 2 | -$28M | |
| 3 | -$24.4M | |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$24.2M |
| 5 |
PM
Pembroke Management
Montreal,
Quebec, Canada
|
-$20.8M |